David Samadi, MD, urologic oncologist, director of males’s well being, St. Francis Hospital, Roslyn, NY.
Otis W. Brawley, MD, Bloomberg distinguished professor of oncology and epidemiology, Johns Hopkins College, Baltimore.
James Eastham, MD, chief, Urology Service, Memorial Sloan Kettering Most cancers Middle, New York Metropolis.
Maurie Markman, MD, medical oncologist; president of medication and science, Most cancers Remedy Facilities of America.
Nationwide Complete Most cancers Community: “NCCN Tips.”
Rachel Darwin, spokeswoman, Nationwide Complete Most cancers Community.
American Urological Affiliation: “Early Detection of Prostate Most cancers.”
The New York Instances: “Debating the Worth of PSA Prostate Screening.”
Urology Instances: “The good prostate most cancers ‘hoax’: A name to arms.”
Premiere Medical Group: “Confronting A Controversy — The PSA Query.”
American Society for Scientific Oncology: “Determination Help Device: Prostate Most cancers Screening With PSA Testing.”
Investigative and Scientific Urology: “Prostate Most cancers Screening.”
Oncotypeiq.com: “In regards to the Oncotype DX Genomic Prostate Rating Assay.”
JAMA Oncology: “Validation of a 22-Gene Genomic Classifier in Sufferers With Recurrent Prostate Most cancers: An Ancillary Examine of the NRG/RTOG 9601 Randomized Scientific Trial.”
CyberKnife.com: “A exact, correct and handy remedy answer for prostate most cancers.”
MDAnderson.org: “Proton Remedy for Prostate Most cancers.”
Urology Right now: “The challenges of prostate most cancers administration.”
American Most cancers Society: “Assessments to Diagnose and Stage Prostate Most cancers,” “What’s New in Prostate Most cancers Analysis.”